TY - CHAP
T1 - Antimicrobial (viral, bacterial, fungal, and parasitic) mechanisms of action of boron-containing compounds
AU - Farfán-García, Eunice D.
AU - Kilic, Ahmet
AU - García-Machorro, Jazmín
AU - Cuevas-Galindo, M. Emilio
AU - Rubio-Velazquez, Brenda A.
AU - García-Coronel, Itzel H.
AU - Estevez-Fregoso, Elizabeth
AU - Trujillo-Ferrara, Jose G.
AU - Soriano-Ursúa, Marvin A.
N1 - Publisher Copyright:
© 2023 Elsevier Inc. All rights reserved.
PY - 2022/1/1
Y1 - 2022/1/1
N2 - Exploration of boron-containing compounds (BBC) has allowed us to introduce them into the antimicrobial toolbox. Natural and synthetic BCC have shown antimicrobial activity in vitro and in vivo. Also, crystal structures and in silico assays have been described to support the safe use to treat infectious diseases in humans. As examples, boric acid, Tavaborole, and Vaborbactam are now available in a human application. In this chapter, we describe the introduction of BCC as antimicrobial agents. This includes the advances in the understanding of their mechanisms of action for limiting viral, bacterial, fungal, and parasitic infections; mainly from the analysis of obtained crystal structures of targeted proteins. In addition, the scope of drug-designing strategies, as well as their chemico-biological properties are found, suggesting advantages in the boron-free compounds, taking into account potential action on drug-resistance microorganisms.
AB - Exploration of boron-containing compounds (BBC) has allowed us to introduce them into the antimicrobial toolbox. Natural and synthetic BCC have shown antimicrobial activity in vitro and in vivo. Also, crystal structures and in silico assays have been described to support the safe use to treat infectious diseases in humans. As examples, boric acid, Tavaborole, and Vaborbactam are now available in a human application. In this chapter, we describe the introduction of BCC as antimicrobial agents. This includes the advances in the understanding of their mechanisms of action for limiting viral, bacterial, fungal, and parasitic infections; mainly from the analysis of obtained crystal structures of targeted proteins. In addition, the scope of drug-designing strategies, as well as their chemico-biological properties are found, suggesting advantages in the boron-free compounds, taking into account potential action on drug-resistance microorganisms.
KW - Antibacterial
KW - Antifungal
KW - Antiparasitic
KW - Antiviral
KW - Boron
KW - Mechanisms of action
KW - Molecular interactions
UR - http://www.scopus.com/inward/record.url?scp=85148708933&partnerID=8YFLogxK
U2 - 10.1016/B978-0-323-85730-7.00026-6
DO - 10.1016/B978-0-323-85730-7.00026-6
M3 - Capítulo
AN - SCOPUS:85148708933
SN - 9780323898003
SP - 733
EP - 754
BT - Viral, Parasitic, Bacterial, and Fungal Infections
PB - Elsevier
ER -